KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Net Income (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Net Income for 4 consecutive years, with -$211.7 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Net Income fell 22.31% year-over-year to -$211.7 million, compared with a TTM value of -$892.9 million through Dec 2023, up 57.62%, and an annual FY2025 reading of -$312.8 million, up 42.83% over the prior year.
  • Net Income was -$211.7 million for Q4 2023 at Ginkgo Bioworks Holdings, up from -$302.9 million in the prior quarter.
  • Across five years, Net Income topped out at -$26.5 million in Q3 2021 and bottomed at -$1.7 billion in Q4 2021.
  • Average Net Income over 4 years is -$360.0 million, with a median of -$189.1 million recorded in 2023.
  • The sharpest move saw Net Income tumbled 2824.17% in 2021, then soared 90.05% in 2022.
  • Year by year, Net Income stood at -$59.5 million in 2020, then crashed by 2824.17% to -$1.7 billion in 2021, then skyrocketed by 90.05% to -$173.1 million in 2022, then decreased by 22.31% to -$211.7 million in 2023.
  • Business Quant data shows Net Income for DNA at -$211.7 million in Q4 2023, -$302.9 million in Q3 2023, and -$173.3 million in Q2 2023.